Bibliographic information
GuidelineWHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year of Publication2020
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
In patients with confirmed rifampicin-susceptible, isoniazid-resistant tuberculosis, it is not recommended to add streptomycin or other injectable agents to the treatment regimen
Recommended against
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines on tuberculosis infection prevention and control: 2019 update
Year2019
InstitutionWHO
Guideline
WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents.
Year2022
InstitutionWHO